By: 1 September 2010

Abstract

Background
Multiple Sclerosis (MS) is primarily a disease of women in their childbearing years. Pregnancy and puerperium have opposite effects on the course of the disease. Nevertheless, no studies have been carried out yet on the level of information among female MS-patients regarding the interaction between MS and pregnancy.

Findings
Demographic data, clinical features of MS, course of MS during pregnancy and puerperium as well as knowledge concerning MS and pregnancy were evaluated by means of a questionnaire in 154 female MS-patients. The level of information was significantly higher (p < 0.001) in women who had been pregnant in the past with the diagnosis MS known at this point of time. Furthermore patients reported about a lower frequency of relapses during pregnancy and a higher frequency of relapses in the first six months after giving birth.

Conclusions
The findings illustrate a lack of knowledge in female MS-patients concerning the interactions of MS and pregnancy. In order to make their own independent decision based on scientific facts known to date, female MS-patients need to be better informed on issues regarding MS and pregnancy.

Introduction
Multiple Sclerosis (MS) is a chronic autoimmune disease of the central nervous system (CNS). It primarily affects premenopausal women1,2. Several studies show, that pregnancy in MS-patients is associated with a lower risk of progression and a lower risk of exacerbation, whereas the relapse rate increases during the first three months post partum 3-6.

There is no effect of pregnancy on the lifetime course of the disease and long term disability4,6. However, it has not been studied yet, to what extent patients know about the interactions between pregnancy and MS and how patients perceive the course of the disease during and after pregnancy. Thus our aims were twofold:

  1. To investigate how patients perceive the course of the disease during and after pregnancy
  2. To evaluate the level of knowledge regarding MS and pregnancy

Methods
Survey sample
Prior to conducting the study, the University of Luebeck Ethics Committee approved the study and the questionnaire. The questionnaire was mailed to 300 women with definitive MS who had been in contact with the Department of Neurology of the University of Luebeck in the past. The study was carried out November 06 – June 07, age of the patients was 18-56 years. Additionally to the questionnaire, the patients were provided a pre-addressed, pre-stamped envelope and were instructed to return their completed questionnaire with no further identifying information.

Questionnaire design
A questionnaire based survey was designed to gather data on the following in female MS-patients:

  1. General demography, course of disease and medical treatment,
  2. Perceived course of MS during and after pregnancy;
  3. Knowledge and personal beliefs regarding:
  • A possible effect of MS on pregnancy
  • A possible effect of pregnancy on MS
  • A possible effect of the puerperium on MS
  • A possible effect of breastfeeding on MS

The questionnaire used was a seven page 31 item survey, the language was German. The questionnaire can be requested from the authors.

Statistics
Analyses were conducted using statistical software (SPSS vs.14 for windows). Data are presented as summary statistics (mean and median as appropriate). Ordered categorical data were summarised as proportions. Significance was set at the 95% level.

Results
154 questionnaires were returned (response rate 51.3%). Data from 150 patients could be analysed. However, since several questions were not answered by all participants of the study, the sample-size varies for single questions.

General demography, course of disease, medical treatment and walking ability
Mean age was 39.3 years, median 40, SD 9. Of 147 female MS-patients, 90 women (61.2%) experienced a relapsing remitting (RR) course of MS, 20 women (13.6%) a secondary progressive (SP) and 6 women (4.1%) a primary progressive (PP) course of MS. 31 patients (21.1%) were not sure about their course of MS. 92 of 149 patients (61.7%) were treated with an immunomodulatory or immunosuppressive agent.

Perceived course of MS during and after pregna